Zacks Investment Research upgraded shares of Tate & Lyle (OTCMKTS:TATYY) from a hold rating to a strong-buy rating in a research report report published on Tuesday morning, Zacks.com reports. Zacks Investment Research currently has $39.00 target price on the stock.
According to Zacks, “Tate & Lyle Ventures and Agri Investment Fund have co-led a 3.5m investment into Fugeia, a newly formed functional food technology business with a focus on gut health. “
A number of other equities research analysts have also commented on the stock. Berenberg Bank restated a hold rating on shares of Tate & Lyle in a report on Wednesday, May 6th. Barclays restated an overweight rating on shares of Tate & Lyle in a report on Thursday, May 28th. ValuEngine lowered shares of Tate & Lyle from a hold rating to a sell rating in a report on Wednesday, May 27th. Investec lowered shares of Tate & Lyle from a hold rating to a sell rating in a report on Wednesday, May 6th. Finally, Jefferies Financial Group upgraded shares of Tate & Lyle from a hold rating to a buy rating in a report on Tuesday, March 31st. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of Hold and an average price target of $39.00.
Tate & Lyle Company Profile
Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products.
Read More: What is the CAC 40 Index?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Tate & Lyle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tate & Lyle and related companies with MarketBeat.com's FREE daily email newsletter.